Suppr超能文献

用于治疗股腘动脉疾病的冷冻球囊血管成形术:一项前瞻性多中心注册研究的结果

Cryoplasty for the treatment of femoropopliteal arterial disease: results of a prospective, multicenter registry.

作者信息

Laird John, Jaff Michael R, Biamino Giancarlo, McNamara Thomas, Scheinert Dierk, Zetterlund Patrick, Moen Elaine, Joye James D

机构信息

Washington Hospital Center, Division of Cardiology, Indianapolis, IN, USA.

出版信息

J Vasc Interv Radiol. 2005 Aug;16(8):1067-73. doi: 10.1097/01.RVI.0000167866.86201.4E.

Abstract

PURPOSE

Despite suboptimal results, angioplasty of femoropopliteal arterial lesions has been a mainstay of endovascular therapy for many years. The recent introduction of cryoplasty marks a potential advance in the ability to effectively treat peripheral arterial atherosclerotic stenoses. This article presents the results of a prospective, multicenter trial that evaluated the efficacy of cryoplasty for femoropopliteal disease.

MATERIALS AND METHODS

One hundred two patients with claudication and lesions of the superficial femoral and popliteal arteries of no greater than 10 cm were studied. All patients were treated with a primary strategy of stand-alone cryoplasty with use of the PolarCath cryoplasty system. The primary endpoints of the study were acute technical success and clinical patency at 9 months. Technical success was defined as the ability to achieve residual angiographic stenosis no greater than 30% and residual stenosis less than 50% by duplex ultrasound (US) imaging. Clinical patency was defined as freedom from target lesion revascularization within 9 months. Primary patency was defined by a duplex US systolic velocity ratio no greater than 2.0.

RESULTS

A total of 102 patients were enrolled at 16 centers. Of those treated, 31% had diabetes and 31% were active cigarette smokers. The majority of the lesions were confined to the superficial femoral artery (84.3%) and 14.7% presented with total occlusions. The mean vessel diameter treated was 5.5 mm +/- 0.5, the mean stenosis diameter was 87% +/- 10%, and the mean lesion length was 4.7 cm +/- 2.6. The technical success rate was 85.3% with a mean residual stenosis after cryoplasty of 11.2% +/- 11.2% (P < .05 vs baseline). Clinical patency in this group was 82.2%, as only 16 patients required target lesion revascularization during the 9-month surveillance period. Primary patency determined by duplex US was 70.1%.

CONCLUSIONS

Cryoplasty demonstrated a high degree of acute angiographic success and a low frequency of target lesion revascularization. The patency rate observed compares favorably to that previously documented with conventional angioplasty.

摘要

目的

尽管结果不尽人意,但股腘动脉病变血管成形术多年来一直是血管内治疗的主要手段。最近引入的冷冻球囊血管成形术标志着在有效治疗外周动脉粥样硬化狭窄能力方面的潜在进展。本文介绍了一项前瞻性多中心试验的结果,该试验评估了冷冻球囊血管成形术治疗股腘动脉疾病的疗效。

材料与方法

对102例患有间歇性跛行且股浅动脉和腘动脉病变不超过10 cm的患者进行研究。所有患者均采用使用PolarCath冷冻球囊血管成形系统的单纯冷冻球囊血管成形术的主要策略进行治疗。该研究的主要终点是9个月时的急性技术成功率和临床通畅率。技术成功定义为血管造影残余狭窄不超过30%且通过双功超声(US)成像残余狭窄小于50%的能力。临床通畅定义为9个月内无需对靶病变进行血管再通。初级通畅由双功超声收缩期速度比不超过2.0定义。

结果

16个中心共纳入102例患者。在接受治疗的患者中,31%患有糖尿病,31%为现吸烟者。大多数病变局限于股浅动脉(84.3%),14.7%表现为完全闭塞。治疗的平均血管直径为5.5 mm±0.5,平均狭窄直径为87%±10%,平均病变长度为4.7 cm±2.6。技术成功率为85.3%,冷冻球囊血管成形术后平均残余狭窄为11.2%±11.2%(与基线相比P<0.05)。该组的临床通畅率为82.2%,因为在9个月的监测期内只有16例患者需要对靶病变进行血管再通。通过双功超声确定的初级通畅率为70.1%。

结论

冷冻球囊血管成形术显示出高度的急性血管造影成功率和低频率的靶病变血管再通。观察到的通畅率与先前传统血管成形术记录的通畅率相比具有优势。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验